Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cerebrolysin in children with cerebral palsy
IRCT201107226907N3Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Aug 2015
- Modality
- Peptide-based Cancer Vaccines → Cancer Vaccines → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Native Peptides → Peptides, Modified Peptides → Peptides
- Countries
- 1
01
Overview
Phase 3 trial of cerebrolysin in cerebral palsy (CP), sponsored by Tehran University of Medical Sciences. Started Aug 2015; status: completed.
02
Drugs
cerebrolysin
03
Conditions
cerebral palsy (CP)
Beyond the preview
Go deeper on IRCT201107226907N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201107226907N3.